Contact this trialFirst, we need to learn more about you.
Procedure
BTX-A51 for Cancer
Recruiting1 awardPhase 1
Lake Mary, Florida
This trial is designed to study the safety and effectiveness of BTX-A51 in people with advanced solid tumors or NHL. The trial will have two parts: in the first part, the dose of BTX-A51 will be increased until the maximum tolerated dose is found; in the second part, the safety and effectiveness of BTX-A51 will be studied in people with MYC genomic amplified/overexpressed tumors.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service